Although HSP90-SUMO1 was reported in a small percentage of controls, only MGUS and MM subjects who were HSP90-SUMO1 carriers produced HSP90-SUMO1-specific paraproteins, suggesting that sumoylated HSP90 contributes to the onset of these conditions (Figure 3). This evidence concerns the gene SUMO1 and Miyoshi myopathy.